The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer

Abstract Purpose Hyaluronan modulates tumour progression, including cell adhesion, cohesion, proliferation and invasion, and the cancer stem cell phenotype. In ovarian cancer, high levels of stromal hyaluronan are associated with poor prognosis. In this work, hyaluronan synthases (HAS1-3) and hyalur...

Full description

Saved in:
Bibliographic Details
Main Authors: Jette Riecks, Arianna Parnigoni, Balázs Győrffy, Ludwig Kiesel, Alberto Passi, Davide Vigetti, Martin Götte
Format: Article
Language:English
Published: Springer 2022-06-01
Series:Journal of Cancer Research and Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1007/s00432-022-04127-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104151585849344
author Jette Riecks
Arianna Parnigoni
Balázs Győrffy
Ludwig Kiesel
Alberto Passi
Davide Vigetti
Martin Götte
author_facet Jette Riecks
Arianna Parnigoni
Balázs Győrffy
Ludwig Kiesel
Alberto Passi
Davide Vigetti
Martin Götte
author_sort Jette Riecks
collection DOAJ
description Abstract Purpose Hyaluronan modulates tumour progression, including cell adhesion, cohesion, proliferation and invasion, and the cancer stem cell phenotype. In ovarian cancer, high levels of stromal hyaluronan are associated with poor prognosis. In this work, hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-4, PH-20, HYALP1) were examined with regard to different levels of gene expression and its influence on ovarian cancer patients’ survival. The impact of a siRNA depletion of HAS2 was investigated in vitro. Methods Using the Kaplan–Meier Plotter tool, we investigated the influence of hyaluronic synthases and hyaluronidases on the survival of a collective of 1435 ovarian cancer patients. Differences in gene expression between normal (n = 46) and cancerous (n = 744) ovarian tissue were examined using the TNMplot database. Following an evaluation of hyaluronan-related gene expression in the ATCC ovarian cancer panel, we studied SKOV3 and SW 626 ovarian cancer cells subjected to HAS2 siRNA or control siRNA treatment in terms of HAS1-3, HYAL2 and HYAL3 mRNA expression. We investigated the ability to form spheroids using the Hanging Drop method and the response to chemotherapy at different concentrations using the MTT Assay. By STRING analysis, interactions within the enzymes of the hyaluronic acid system and with binding partners were visualized. Results HAS1, HYAL1 and HYAL4 mRNA expression is significantly upregulated, whereas HAS2, HYAL2 and HYAL3 mRNA expression is significantly downregulated in ovarian cancer tissue compared to controls. HAS2 improves cell viability, the capability to form tumour spheroids and has a negative prognostic value regarding overall survival. Lower HAS2 expression and high expression of HYAL2 and HYAL3 favours the survival of ovarian cancer patients. HAS2 knockdown cells and control cells showed a moderate response to combinatorial in vitro chemotherapy with taxol and cisplatin. Conclusion In conclusion, our study shows that the hyaluronic acid system has a relevant influence on the survival of ovarian cancer patients and could therefore be considered as a possible prognostic factor.
format Article
id doaj-art-96f8aafe062d4abb8d0974ac67eced51
institution DOAJ
issn 0171-5216
1432-1335
language English
publishDate 2022-06-01
publisher Springer
record_format Article
series Journal of Cancer Research and Clinical Oncology
spelling doaj-art-96f8aafe062d4abb8d0974ac67eced512025-08-20T02:39:23ZengSpringerJournal of Cancer Research and Clinical Oncology0171-52161432-13352022-06-01148123399341910.1007/s00432-022-04127-6The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancerJette Riecks0Arianna Parnigoni1Balázs Győrffy2Ludwig Kiesel3Alberto Passi4Davide Vigetti5Martin Götte6Department of Gynecology and Obstetrics, Münster University HospitalDepartment of Gynecology and Obstetrics, Münster University HospitalDepartment of Bioinformatics, Semmelweis UniversityDepartment of Gynecology and Obstetrics, Münster University HospitalDepartment of Medicine and Surgery, University of InsubriaDepartment of Medicine and Surgery, University of InsubriaDepartment of Gynecology and Obstetrics, Münster University HospitalAbstract Purpose Hyaluronan modulates tumour progression, including cell adhesion, cohesion, proliferation and invasion, and the cancer stem cell phenotype. In ovarian cancer, high levels of stromal hyaluronan are associated with poor prognosis. In this work, hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-4, PH-20, HYALP1) were examined with regard to different levels of gene expression and its influence on ovarian cancer patients’ survival. The impact of a siRNA depletion of HAS2 was investigated in vitro. Methods Using the Kaplan–Meier Plotter tool, we investigated the influence of hyaluronic synthases and hyaluronidases on the survival of a collective of 1435 ovarian cancer patients. Differences in gene expression between normal (n = 46) and cancerous (n = 744) ovarian tissue were examined using the TNMplot database. Following an evaluation of hyaluronan-related gene expression in the ATCC ovarian cancer panel, we studied SKOV3 and SW 626 ovarian cancer cells subjected to HAS2 siRNA or control siRNA treatment in terms of HAS1-3, HYAL2 and HYAL3 mRNA expression. We investigated the ability to form spheroids using the Hanging Drop method and the response to chemotherapy at different concentrations using the MTT Assay. By STRING analysis, interactions within the enzymes of the hyaluronic acid system and with binding partners were visualized. Results HAS1, HYAL1 and HYAL4 mRNA expression is significantly upregulated, whereas HAS2, HYAL2 and HYAL3 mRNA expression is significantly downregulated in ovarian cancer tissue compared to controls. HAS2 improves cell viability, the capability to form tumour spheroids and has a negative prognostic value regarding overall survival. Lower HAS2 expression and high expression of HYAL2 and HYAL3 favours the survival of ovarian cancer patients. HAS2 knockdown cells and control cells showed a moderate response to combinatorial in vitro chemotherapy with taxol and cisplatin. Conclusion In conclusion, our study shows that the hyaluronic acid system has a relevant influence on the survival of ovarian cancer patients and could therefore be considered as a possible prognostic factor.https://doi.org/10.1007/s00432-022-04127-6Ovarian cancerHyaluronidasesHyaluronan synthasesHAS2Gene expressionSurvival analysis
spellingShingle Jette Riecks
Arianna Parnigoni
Balázs Győrffy
Ludwig Kiesel
Alberto Passi
Davide Vigetti
Martin Götte
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
Journal of Cancer Research and Clinical Oncology
Ovarian cancer
Hyaluronidases
Hyaluronan synthases
HAS2
Gene expression
Survival analysis
title The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
title_full The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
title_fullStr The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
title_full_unstemmed The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
title_short The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
title_sort hyaluronan related genes has2 hyal1 4 ph20 and hyalp1 are associated with prognosis cell viability and spheroid formation capacity in ovarian cancer
topic Ovarian cancer
Hyaluronidases
Hyaluronan synthases
HAS2
Gene expression
Survival analysis
url https://doi.org/10.1007/s00432-022-04127-6
work_keys_str_mv AT jetteriecks thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT ariannaparnigoni thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT balazsgyorffy thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT ludwigkiesel thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT albertopassi thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT davidevigetti thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT martingotte thehyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT jetteriecks hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT ariannaparnigoni hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT balazsgyorffy hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT ludwigkiesel hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT albertopassi hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT davidevigetti hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer
AT martingotte hyaluronanrelatedgeneshas2hyal14ph20andhyalp1areassociatedwithprognosiscellviabilityandspheroidformationcapacityinovariancancer